GEP- NETS UPDATE: Genetics of neuroendocrine tumors (Q26750737)

European Journal of Endocrinology

Europe PubMed Central

title

GEP- NETS UPDATE: Genetics of neuroendocrine tumors (English)

0 references

author name string

Joakim Crona

series ordinal

1

0 references

Britt Skogseid

series ordinal

2

0 references

language of work or name

English

0 references

publication date

June 2016

0 references

published in

0 references

volume

174

0 references

page(s)

R275-90

0 references

issue

6

0 references

cites work

Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi-institutional clinicopathologic study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The genomic landscape of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Clonality analysis of multifocal carcinoid tumours of the small intestine by X-chromosome inactivation analysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Genetic aspects of nonchromaffin paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Genetic aspects of adenomatosis of endocrine glands

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The association of pheochromocytoma with carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Ocular manifestations of hypoxia-inducible factor-2α paraganglioma-somatostatinoma-polycythemia syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

https://api.crossref.org/works/10.1530%2FEJE-15-0972

1 reference

7 January 2021

Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Evidence for APOBEC3B mutagenesis in multiple human cancers

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

PHD2 mutation and congenital erythrocytosis with paraganglioma.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Ceritinib in ALK-rearranged non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Response and acquired resistance to everolimus in anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Medullary thyroid cancer: management guidelines of the American Thyroid Association

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

SDHA is a tumor suppressor gene causing paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Epidemiology of tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Altered telomeres in tumors with ATRX and DAXX mutations

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Positional cloning of the gene for multiple endocrine neoplasia-type 1

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Genetic screening for pheochromocytoma: should SDHC gene analysis be included?

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Von Hippel-Lindau disease: a genetic study

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome)

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Targeting the RET pathway in thyroid cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The genomic landscape of small intestine neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple Simultaneous Paragangliomas of The Head and Neck in Association with Multiple Retroperitoneal Pheochromocytomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Circulating tumor cells as prognostic markers in neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

New syndrome of paraganglioma and somatostatinoma associated with polycythemia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of somatic mutations in parathyroid tumors using whole-exome sequencing

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Germline FH mutations presenting with pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Different gene expression profiles in metastasizing midgut carcinoid tumors.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Exome sequencing reveals mutant genes with low penetrance involved in MEN2A-associated tumorigenesis.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Evidence for a heritable contribution to neuroendocrine tumors of the small intestine

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021

Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas

1 reference

https://api.crossref.org/works/10.1530%2FEJE-15-0972

7 January 2021